Pathology


Simple Test Could Reduce Treatment of Bladder Cancer
Bladder cancer is relatively common and imposes the highest per patient cost on the healthcare system of the USA than the management of any other cancer type. Most bladder cancers are early-stage tumors known as papillary non-muscle-invasive bladder cancer (NMIBC). More...09 Jul 2018





In Other News
Vaginal Bacteria Linked to Cervical Cancer
Biochip Developed to Detect Prostate Cancer Cells
Post-Cardiac Surgery Infection Associated with Different Diseases
MSI Tumor Analysis Implicates Lynch Syndrome in Cancer Types
Hormone Levels Alter CVD Risk in Older Women
Hereditary Breast Cancer Tests Double Detection Rate
Genetic Predisposition Validated in Medulloblastoma
Molecular Subtype Identified for CRCs Metastasized to Liver
Cell Block Prep Method Modified for Molecular Studies
Thyroid Cancer Genetics Study Finds New Mutations
Breath and Urine Tests Detect Early Breast Cancer
Biomarkers Identified for Irritable Bowel Syndrome
Cancer Blood Test Engineered to Detect Tumors Early
Streamlined Approach Discovered for Treating Bowel Cancer
Molecular Technology Identifies Potential Biomarker for Cancer
Image Analysis System Quantifies NASH Disease Activity
Genetic Variant Identified As Better Marker for CV Disease
Amyloid Blood Biomarker Detects Alzheimer's Disease
Confocal Fluorescence Microscopy Used for Rapid Tissue Evaluation
Sampling Device Increases Detection of Barrett’s Esophagus
Aggressive Meningioma Linked to Transcription Factor Activity
Gut Microbiome Analysis Predicts Hospitalizations in Cirrhosis
Genomic Test Detects Lynch Syndrome in Colorectal Cancer
The Pathology channel details advances in the field of Surgical Pathology and all its subspecialties, including Cytopathology and its subspecialties.